A single histrelin implant is effective for 2 years for treatment of central precocious puberty.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 23809043.
- Also identified by DOI 10.1016/j.jpeds.2013.05.033 and PMC identifier 4063525.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We investigated whether a "yearly" histrelin implant would provide pubertal suppression when left in place for 2 years. Equivalent suppression was observed when comparing 12 and 24 months in 33 children with central precocious puberty. A single implant for 2 years reduces cost and number of implant procedures.
Medical subject headings
- Drug Implants
- Gonadotropin-Releasing Hormone
- Puberty, Precocious